BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 15146183)

  • 1. Acute myeloid leukemia induced by graded reduction of a lineage-specific transcription factor, PU.1.
    Rosenbauer F; Wagner K; Kutok JL; Iwasaki H; Le Beau MM; Okuno Y; Akashi K; Fiering S; Tenen DG
    Nat Genet; 2004 Jun; 36(6):624-30. PubMed ID: 15146183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PU.1 promotes cell cycle exit in the murine myeloid lineage associated with downregulation of E2F1.
    Ziliotto R; Gruca MR; Podder S; Noel G; Ogle CK; Hess DA; DeKoter RP
    Exp Hematol; 2014 Mar; 42(3):204-217.e1. PubMed ID: 24316397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of concentration-dependent functions of PU.1 in hematopoiesis using mouse models.
    DeKoter RP; Kamath MB; Houston IB
    Blood Cells Mol Dis; 2007; 39(3):316-20. PubMed ID: 17629523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aggressive acute myeloid leukemia in PU.1/p53 double-mutant mice.
    Basova P; Pospisil V; Savvulidi F; Burda P; Vargova K; Stanek L; Dluhosova M; Kuzmova E; Jonasova A; Steidl U; Laslo P; Stopka T
    Oncogene; 2014 Sep; 33(39):4735-45. PubMed ID: 24121269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A distal single nucleotide polymorphism alters long-range regulation of the PU.1 gene in acute myeloid leukemia.
    Steidl U; Steidl C; Ebralidze A; Chapuy B; Han HJ; Will B; Rosenbauer F; Becker A; Wagner K; Koschmieder S; Kobayashi S; Costa DB; Schulz T; O'Brien KB; Verhaak RG; Delwel R; Haase D; Trümper L; Krauter J; Kohwi-Shigematsu T; Griesinger F; Tenen DG
    J Clin Invest; 2007 Sep; 117(9):2611-20. PubMed ID: 17694175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced PU.1 expression causes myeloid progenitor expansion and increased leukemia penetrance in mice expressing PML-RARalpha.
    Walter MJ; Park JS; Ries RE; Lau SK; McLellan M; Jaeger S; Wilson RK; Mardis ER; Ley TJ
    Proc Natl Acad Sci U S A; 2005 Aug; 102(35):12513-8. PubMed ID: 16113082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sfpi1/PU.1 mutations in mouse radiation-induced acute myeloid leukaemias affect mRNA and protein abundance and associate with disrupted transcription.
    Brown NL; Finnon R; Bulman RA; Finnon P; Moody J; Bouffler SD; Badie C
    Leuk Res; 2011 Jan; 35(1):126-32. PubMed ID: 20638124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of radiation quality on mouse chromosome 2 deletions in radiation-induced acute myeloid leukaemia.
    Brown N; Finnon R; Manning G; Bouffler S; Badie C
    Mutat Res Genet Toxicol Environ Mutagen; 2015 Nov; 793():48-54. PubMed ID: 26520372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Essential role of Jun family transcription factors in PU.1 knockdown-induced leukemic stem cells.
    Steidl U; Rosenbauer F; Verhaak RG; Gu X; Ebralidze A; Otu HH; Klippel S; Steidl C; Bruns I; Costa DB; Wagner K; Aivado M; Kobbe G; Valk PJ; Passegué E; Libermann TA; Delwel R; Tenen DG
    Nat Genet; 2006 Nov; 38(11):1269-77. PubMed ID: 17041602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Down-regulation of Notch-1 expression decreases PU.1-mediated myeloid differentiation signaling in acute myeloid leukemia.
    Chen PM; Yen CC; Wang WS; Lin YJ; Chu CJ; Chiou TJ; Liu JH; Yang MH
    Int J Oncol; 2008 Jun; 32(6):1335-41. PubMed ID: 18497996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osteopetrosis in mice lacking haematopoietic transcription factor PU.1.
    Tondravi MM; McKercher SR; Anderson K; Erdmann JM; Quiroz M; Maki R; Teitelbaum SL
    Nature; 1997 Mar; 386(6620):81-4. PubMed ID: 9052784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Essential role of PU.1 in maintenance of mixed lineage leukemia-associated leukemic stem cells.
    Aikawa Y; Yamagata K; Katsumoto T; Shima Y; Shino M; Stanley ER; Cleary ML; Akashi K; Tenen DG; Kitabayashi I
    Cancer Sci; 2015 Mar; 106(3):227-36. PubMed ID: 25529853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Minimal PU.1 reduction induces a preleukemic state and promotes development of acute myeloid leukemia.
    Will B; Vogler TO; Narayanagari S; Bartholdy B; Todorova TI; da Silva Ferreira M; Chen J; Yu Y; Mayer J; Barreyro L; Carvajal L; Neriah DB; Roth M; van Oers J; Schaetzlein S; McMahon C; Edelmann W; Verma A; Steidl U
    Nat Med; 2015 Oct; 21(10):1172-81. PubMed ID: 26343801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PU.1 regulates both cytokine-dependent proliferation and differentiation of granulocyte/macrophage progenitors.
    DeKoter RP; Walsh JC; Singh H
    EMBO J; 1998 Aug; 17(15):4456-68. PubMed ID: 9687512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upregulation of c-myc gene accompanied by PU.1 deficiency in radiation-induced acute myeloid leukemia in mice.
    Hirouchi T; Takabatake T; Yoshida K; Nitta Y; Nakamura M; Tanaka S; Ichinohe K; Oghiso Y; Tanaka K
    Exp Hematol; 2008 Jul; 36(7):871-85. PubMed ID: 18375040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PU.1 downregulation in murine radiation-induced acute myeloid leukaemia (AML): from molecular mechanism to human AML.
    Verbiest T; Bouffler S; Nutt SL; Badie C
    Carcinogenesis; 2015 Apr; 36(4):413-9. PubMed ID: 25750172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leukemogenesis in heterozygous PU.1 knockout mice.
    Genik PC; Vyazunova I; Steffen LS; Bacher JW; Bielefeldt-Ohmann H; McKercher S; Ullrich RL; Fallgren CM; Weil MM; Ray FA
    Radiat Res; 2014 Sep; 182(3):310-5. PubMed ID: 25076114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PU.1 is a major downstream target of AML1 (RUNX1) in adult mouse hematopoiesis.
    Huang G; Zhang P; Hirai H; Elf S; Yan X; Chen Z; Koschmieder S; Okuno Y; Dayaram T; Growney JD; Shivdasani RA; Gilliland DG; Speck NA; Nimer SD; Tenen DG
    Nat Genet; 2008 Jan; 40(1):51-60. PubMed ID: 17994017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of transcription factors C/EBPalpha and PU.1 in normal hematopoiesis and leukemia.
    Koschmieder S; Rosenbauer F; Steidl U; Owens BM; Tenen DG
    Int J Hematol; 2005 Jun; 81(5):368-77. PubMed ID: 16158816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction in PU.1 activity results in a block to B-cell development, abnormal myeloid proliferation, and neonatal lethality.
    Houston IB; Kamath MB; Schweitzer BL; Chlon TM; DeKoter RP
    Exp Hematol; 2007 Jul; 35(7):1056-68. PubMed ID: 17588474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.